RT Journal Article
SR Electronic
T1 666 Safety, efficacy, and biomarker results of SRK-181, a latent TGFβ1 inhibitor, in anti-PD-1 resistant metastatic ccRCC patients
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A756
OP A756
DO 10.1136/jitc-2023-SITC2023.0666
VO 11
IS Suppl 1
A1 Yap, Timothy
A1 Vaishampayan, Ulka N
A1 Kilari, Deepak
A1 Sweis, Randy
A1 Barve, Minal
A1 Gainor, Justin
A1 Tarhini, Ahmad A
A1 Karim, Raghad
A1 Sher, Amna
A1 Park, David
A1 Babu, Sunil
A1 McKay, Rana
A1 Ju, Yawen
A1 Liu, Lan
A1 Henry, Susan
A1 Gan, Lu
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A756.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.